Epilepsy and brain tumors

被引:115
作者
Ruda, Roberta [1 ]
Trevisan, Elisa
Soffietti, Riccardo
机构
[1] San Giovanni Battista Hosp, Div Neurooncol, Dept Neurosci, I-10126 Turin, Italy
关键词
brain tumors; epilepsy; pathogenesis; pharmakoresistance; treatments; LOW-GRADE GLIOMAS; MEDICALLY INTRACTABLE EPILEPSY; GAMMA-KNIFE RADIOSURGERY; GLIONEURONAL TUMORS; SURGICAL-TREATMENT; P-GLYCOPROTEIN; TEMOZOLOMIDE CHEMOTHERAPY; FUNCTIONAL CONNECTIVITY; PRELIMINARY EXPERIENCE; GLIOBLASTOMA PATIENTS;
D O I
10.1097/CCO.0b013e32833de99d
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review To present an overview of the recent findings in pathophysiology and management of epileptic seizures in patients with brain tumors. Recent findings Low-grade gliomas are the most epileptogenic brain tumors. Regarding pathophysiology, the role of peritumoral changes [hypoxia and acidosis, blood-brain barrier (BBB) disruption, increase or decrease of neurotransmitters and receptors] are of increasing importance. Tumor-associated epilepsy and tumor growth could have some common molecular pathways. Total/subtotal surgical resection (with or without epilepsy surgery) allows a seizure control in a high percentage of patients. Radiotherapy and chemotherapy as well have a role. New antiepileptic drugs are promising, both in terms of efficacy and tolerability. The resistance to antiepileptic drugs is still a major problem: new insights into pathogenesis are needed to develop strategies to manipulate the pharmakoresistance. Summary Epileptic seizures in brain tumors have been definitely recognized as one of the major problems in patients with brain tumors, and need specific and multidisciplinary approaches.
引用
收藏
页码:611 / 620
页数:10
相关论文
共 117 条
[91]   Differential cellular gene expression in ganglioglioma [J].
Samadani, Uzma ;
Judkins, Alexander R. ;
Akpalu, Albert ;
Aronica, Eleonora ;
Crino, Peter B. .
EPILEPSIA, 2007, 48 (04) :646-653
[92]   RETRACTED: Brain tumor and seizures:: Pathophysiology and its implications for treatment revisited (Retracted Article. vol 44, pg 1463, 2003) [J].
Schaller, B ;
Rüegg, SJ .
EPILEPSIA, 2003, 44 (09) :1223-1232
[93]   Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy [J].
Schramm, J ;
Luyken, C ;
Urbach, H ;
Fimmers, R ;
Blümcke, I .
NEUROSURGERY, 2004, 55 (02) :340-347
[94]  
Schröttner O, 2002, ACT NEUR S, V84, P49
[95]   Brain tumors and epilepsy: pathophysiology of peritumoral changes [J].
Shamji, Mohammed F. ;
Fric-Shamji, Elana C. ;
Benoit, Brien G. .
NEUROSURGICAL REVIEW, 2009, 32 (03) :275-284
[96]   Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors [J].
Siomin, V ;
Angelov, L ;
Li, L ;
Vogelbaum, MA .
JOURNAL OF NEURO-ONCOLOGY, 2005, 74 (02) :211-215
[97]   Seizure prophylaxis in patients with brain tumors: A meta-analysis [J].
Sirven, JI ;
Wingerchuk, DA ;
Drazkowsici, JF ;
Lyons, MK ;
Zimmerman, RS .
MAYO CLINIC PROCEEDINGS, 2004, 79 (12) :1489-1494
[98]   PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas [J].
Soffietti, R ;
Rudà, R ;
Bradac, GB ;
Schiffer, D .
NEUROSURGERY, 1998, 43 (05) :1066-1073
[99]   Temozolomide (TMZ) 1 week on/1 week off as initial treatment for progressive low grade oligodendroglial tumors: A phase II AINO study [J].
Soffietti, R. ;
Ruda, R. ;
Trevisan, E. ;
Laguzzi, E. ;
Guarneri, D. ;
Bomprezzi, C. ;
Caroli, M. ;
Leoncini, B. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[100]  
SOFFIETTI R, EUR J NEURO IN PRESS